Invention Grant
- Patent Title: C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders
-
Application No.: US14957463Application Date: 2015-12-02
-
Publication No.: US09771581B2Publication Date: 2017-09-26
- Inventor: Sergei M. Gryaznov , Daria Zielinska , Ronald A. Pruzan , Jeffrey N. Lindquist
- Applicant: Geron Corporation
- Applicant Address: US CA Menlo park
- Assignee: Geron Corporation
- Current Assignee: Geron Corporation
- Current Assignee Address: US CA Menlo park
- Agency: Bozicevic, Field & Francis LLP
- Agent Glenn J. Foulds; Carol L. Francis
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113
Abstract:
Provided herein are antisense oligonucleotides that can effectively prevent or decrease c-myc protein expression as well as decrease overall rates of cell proliferation in in vitro and mammalian in vivo models of cell proliferative disorders as well as methods for using the same.
Public/Granted literature
- US20160186173A1 C-MYC ANTISENSE OLIGONUCLEOTIDES AND METHODS FOR USING THE SAME TO TREAT CELL-PROLIFERATIVE DISORDERS Public/Granted day:2016-06-30
Information query
